← Every company
Fate Therapeutics Inc SEC Filings
What Fate Therapeutics Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
FATE overview →Filings on file
130
since Nov 7, 2016
Warning signs
1
latest Apr 19, 2023
Last results
Aug 13, 2026
8-K item 2.02
Industry
Biological Products, (No Diagnostic Substances)
SIC 2836
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Jun 15, 2026 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Oct 14, 2025 | Executive or director change 8-K | Read ↗ |
| May 30, 2025 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Jan 6, 2025 | Executive or director change 8-K | Read ↗ |
| Nov 29, 2024 | Executive or director change 8-K | Read ↗ |
| Aug 30, 2024 | Executive or director changeMaterial agreement 8-K | Read ↗ |
| Jul 31, 2024 | Executive or director change 8-K | Read ↗ |
| Jun 7, 2024 | Executive or director changeShareholder vote 8-K | Read ↗ |
| May 31, 2024 | Executive or director change 8-K | Read ↗ |
| Jun 8, 2023 | Executive or director change 8-K | Read ↗ |
| Jan 5, 2023 | Executive or director changeRestructuringMaterial agreement 8-K | Read ↗ |
| Jun 13, 2022 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Aug 4, 2021 | Executive or director change 8-K | Read ↗ |
| Mar 25, 2021 | Executive or director change 8-K | Read ↗ |
| Aug 19, 2020 | Executive or director change 8-K | Read ↗ |
| May 5, 2020 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Jul 17, 2019 | Executive or director change 8-K | Read ↗ |
| Mar 18, 2019 | Executive or director change 8-K | Read ↗ |
| Nov 7, 2018 | Executive or director change 8-K | Read ↗ |
| Aug 1, 2018 | Executive or director change 8-K | Read ↗ |
| Jun 1, 2018 | Executive or director changeMaterial agreement 8-K | Read ↗ |
| Jan 17, 2018 | Executive or director change 8-K | Read ↗ |
Source: Fate Therapeutics Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.